Home

Home - Page 49

Global Pharmaceutical Linkage Regulations: A Proposed Analytical Framework

POR JUAN LUIS SERRANO Prompt and affordable access to essential medicines is a component of almost all domestic and global public health models. As is now well known, the availability and costs of both brand and generic drugs is a function of traditional patent law incentives. Less known, however, is that generic entry is controlled increasingly […]

Read More

Life Sciences – Product regulation and liability in Mexico

by Alejandro Luna, Alejandro Torres, Ingrid Ortíz and Laura Medina Trends and developments Legal developments Are there any notable trends or recent legal developments in your jurisdiction’s pharmaceutical industry? It is expected that the North American Free Trade Agreement will be soon reviewed, renegotiated or terminated. However, there is a degree of uncertainty about the issue. Legal framework Legislation [...]
Read More

Commercialisation of Healthcare in Mexico: Overview

by Alejandro Luna Fandiño, Erwin Cruz and Ingrid Ortiz A Q&A guide to the commercialisation of healthcare in Mexico. This Q&A provides an overview of the regulatory framework for the commercialisation of medical products in Mexico. It covers the key requirements for manufacturing, advertising and selling drugs, medical devices, biological products and natural health products. To compare answers across [...]
Read More

Mexican Linkage Gazette April 2011

MEXICAN LINKAGE GAZETTE APRIL 2011 Esta gaceta tiene el propósito de cumplir lo señalado en el Decreto por el que se adiciona el artículo 47 bis del Reglamento de la Ley 3 de la Propiedad Industrial, publicado en el Diario Oficial de la Federación el 19 de septiembre del 2003, donde se establece:Artículo 47 bis. [...]
Read More
+(1200)-0989-568-331
Call us anytime
bearsthemes@gmail.com
Drop us a line anytime!
Office Center
PO Box 16122 Collins Street West